本文へスキップ

研究業績publications


Publications >>NCBI link

2019年


Shirai T, Hirai K, Gon Y, Maruoka S, Mizumura K, Hikichi M, Itoh K, Hashimoto S.
Forced Oscillation Technique May Identify Severe Asthma

J Allergy Clin Immunol Pract. in press (2019)

Yamada T, Saito T, Shimizu Y, Tsukakoshi K, Hayashi H, Mizuno H, Tsuji D, Yamamoto K, Itoh K, Toyo'oka T, Ikebukuro K, Todoroki K.
Anti-Idiotype DNA Aptamer Affinity Purification?High-Temperature Reversed-Phase Liquid Chromatography: A Simple, Accurate, and Selective Bioanalysis of Bevacizumab

Molecules. 24:857 (2019)

Yamamoto K, Sasano T, Tsuji D, Ishizuka Y, Tokou U, Nakamichi H, Yoneda T, Shiokawa M, Yabe K.
A Retrospective Analysis of the Effects of Chemotherapy-Induced Neutropenia on Overall Survival in Patients With Unresectable or Metastatic Urothelial Carcinoma to Gemcitabine Plus Cisplatin Combination Chemotherapy

Ann Pharmacother. 53:690-696 (2019)

Shirai T, Hirai K, Gon Y, Maruoka S, Mizumura K, Hikichi M, Itoh K, Hashimoto S.
Forced oscillation technique may identify asthma-COPD overlap

Allergol Int. in press (2019)

Suzuki T, Shirai T, Hirai K, Tanaka Y, Watanabe H, Endo Y, Shimoda Y, Saigusa M, Akamatsu T, Yamamoto A, Morita S, Asada K.
Improved cough- and sputum-related quality of life after initiation of treatment in pulmonary tuberculosis

Respir Investig. 57:252-259 (2019)

Tsuji D, Suzuki K, Kawasaki Y, Goto K, Matsui R, Seki N, Hashimoto H, Hama T, Yamanaka T, Yamamoto N, Itoh K.
Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial

Support Care Cancer. 27:1139-1147 (2019)

Watanabe H, Shirai T, Akamatsu T, Asada K, Hirai K.
Forced oscillatory parameters in reversibility testing as predictors for chronic cough responsive to inhaled corticosteroid/long-acting β2 agonist

Ann Allergy Asthma Immunol. 122:345-346 (2019)

Shirai T, Hirai K, Gon Y, Maruoka S, Mizumura K, Hikichi M, Holweg C, Itoh K, Inoue H, Hashimoto S.
Combined assessment of serum periostin and YKL-40 may identify asthma-COPD overlap

J Allergy Clin Immunol Pract. 7:134-145.e1 (2019)

Danese E, Raimondi S, Montagnana M, Tagetti A, Langaee T, Borgiani P, Ciccacci C, Carcas AJ, Borobia AM, Tong HY, Davila-Fajardo C, Botton MR, Bourgeois S, Deloukas P, Caldwell MD, Burmester JK, Berg RL, Cavallari LH, Drozda K, Huang M, Zhao LZ, Cen HJ, Gonzalez-Conejero R, Roldan V, Nakamura Y, Mushiroda T, Gong IY, Kim RB, Hirai K, Itoh K, Isaza C, Beltran L, Jimenez-Varo E, Canadas-Garre M, Giontella A, Kringen MK, Bente Foss Haug K, Gwak HS, Lee KE, Minuz P, Lee MTM, Lubitz SA, Scott S, Mazzaccara C, Sacchetti L, Genc E, Ozer M, Pathare A, Krishnamoorthy R, Paldi A, Siguret V, Loriot MA, Kutala VK, Suarez-Kurtz G, Perini J, Denny JC, Ramirez AH, Mittal B, Rathore SS, Sagreiya H, Altman R, Shahin MHA, Khalifa SI, Limdi NA, Rivers C, Shendre A, Dillon C, Suriapranata IM, Zhou HH, Tan SL, Tatarunas V, Lesauskaite V, Zhang Y, Maitland-van der Zee AH, Verhoef TI, de Boer A, Taljaard M, Zambon CF, Pengo V, Zhang JE, Pirmohamed M, Johnson JA, Fava C.
The effect of CYP4F2, VKORC1 and CYP2C9 in influencing coumarin dose. A single patient data meta-analysis in more than 15,000 individuals

Clin Pharmacol Ther. 105:1477-1491 (2019)

2018年


Shimizu H, Suzuki K, Uchikura T, Tsuji D, Yamanaka T, Hashimoto H, Goto K, Matsui R, Seki N, Shimada T, Ikeda S, Ikegami N, Hama T, Yamamoto N, Sasaki T.
Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)

J Pharm Health Care Sci. 4:31 (2018)

Ishii H, Hirai K, Sugiyama K, Nakatani E, Kimura M, Itoh K.
Validation of a nomogram for achieving target trough concentration of vancomycin: accuracy in patients with augmented renal function

Ther Drug Monit. 40:693-698 (2018)

Ohno Y, Niwa T, Hirai K, Suzuki K, Yamada Y, Hayashi Y, Hayashi H, Suzuki A, Itoh Y.
Time-Dependent Decline in Serum Phenytoin Concentration with Heightened Convulsive Seizure Risk by Prolonged Administration of Fosphenytoin in Japanese: A Retrospective Study

Ther Drug Monit. 40:507-511 (2018)

Hirai K, Shirai T, Suzuki M, Shimomura T, Itoh K.
Association between (CCTTT)n repeat polymorphism in NOS2 promoter and asthma exacerbations

J Allergy Clin Immunol. 142:663-665.e3 (2018)

Yokoi M, Tsuji D, Suzuki K, Kawasaki Y, Nakao M, Ayuhara H, Kogure Y, Shibata K, Hayashi T, Hirai K, Inoue K, Hama T, Takeda K, Nishio M, Itoh K.
Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy

Support Care Cancer. 26:1505-1513 (2018)

Egami Y, Narushima Y, Ohshima M, Yoshida A, Yoneta N, Masaki Y, Itoh K.
Human recombinant Fab fragment from combinatorial libraries of a B-cell lymphoma patient recognizes core protein of chondroitin sulfate proteoglycan 4

Journal of Biochemistry. 163:61-68 (2018)

2017年


Keita Hirai, Toshihiro Shirai, Masayuki Suzuki, Taisuke Akamatsu, Takahito Suzuki, Ichiro Hayashi, Akito Yamamoto, Takefumi Akita, Satoru Morita, Kazuhiro Asada, Daiki Tsuji, Kazuyuki Inoue, Kunihiko Itoh.

A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype

Clinical & Experimental Allergy, 47, 1374-1382 (2017)

Otake A, Tsuji D, Taku K, Kawasaki Y, Yokoi M, Nakamori H, Osada M, Matsumoto M, Inoue K, Hirai K, Itoh K.

Chemotherapy-induced neutropenia as a prognostic factor in patients with metastatic pancreatic cancer treated with gemcitabine

Eur J Clin Pharmacol, 73, 1033-1039 (2017)

Tsuji D, Yokoi M, Suzuki K, Daimon T, Nakao M, Ayuhara H, Kogure Y, Shibata K, Hayashi T, Hirai K, Inoue K, Hama T, Takeda K, Nishio M, Itoh K.

Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study

Pharmacogenomics J, 17, 435-440 (2017)

幕田 龍辻 大樹,金 容壱,山本圭祐,大嶽亜季横井茉里中森春美井上和幸平井啓太,中道秀徳,塩川 満,伊藤邦彦.

ドキソルビシン/シクロホスファミド併用療法施行乳がん患者における化学療法誘発性悪心・嘔吐に対するアプレピタントの効果の検討

医療薬学, 43,1-8 (2017)

2016年


Tsuji D, Ikeda M, Yamamoto K, Nakamori H, Kim Y, Kawasaki Y, Otaki A, Yokoi M, Inoue K, Hirai K, Nakamichi H, Tokou U, Shiokawa M, Itoh K.

Drug-related genetic polymorphisms affecting severe chemotherapy-induced neutropenia in breast cancer patients: A hospital-based observational study

Medicine, 95, e5151 (2016)

Hirai K, Ishii H, Shimoshikiryo T, Shimomura T, Tsuji D, Inoue K, Kadoiri T, Itoh K.

Augmented renal clearance in patients with febrile neutropenia is associated with increased risk for subtherapeutic concentrations of vancomycin

Ther Drug Monit, 38, 706-710 (2016)

Hirai K, Shimomura T, Moriwaki H, Ishii H, Shimoshikiryo T, Tsuji D, Inoue K, Kadoiri T, Itoh K.

Risk factors for hypernatremia in patients with short- and long-term tolvaptan treatment

Eur J Clin Pharmacol, 72, 1177-1183 (2016)

Inoue K, Murofushi T, Nagaoka K, Ando N, Hakamata Y, Suzuki A, Umemura A, Yoshida Y, Hirai K, Tsuji D, Itoh K.

Influence of genetic polymorphisms and concomitant anxiolytic doses on antidepressant maintenance doses in Japanese patients with depression

Biol Pharm Bull, 39, 1508-1513 (2016)

Todoroki K, Nakano T, Eda Y, Ohyama K, Hayashi H, Tsuji D, Min JZ, Inoue K, Iwamoto N, Kawakami A, Ueki Y, Itoh K, Toyo'oka T.

Bioanalysis of bevacizumab and infliximab by high-temperature reversed-phase liquid chromatography with fluorescence detection after immunoaffinity magnetic purification

Anal Chim Acta, 916, 112-119 (2016)

Inoue K, Yamamoto Y, Suzuki E, Takahashi T, Umemura A, Takahashi Y, Imai K, Inoue Y, Hirai K, Tsuji D, Itoh K.

Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy

Eur J Clin Pharmacol, 72, 555-562 (2016)

Hirai K, Ihara S, Kinae A, Ikegaya K, Suzuki M, Hirano K, Itoh K.

Augmented renal clearance in pediatric patients with febrile neutropenia associated with vancomycin clearance

Ther Drug Monit, 38, 393-397 (2016)

櫻井健史, 平井啓太, 杉山慎一, 石井英俊, 伊藤邦彦, 角入壽彦.

リファンピシンとアムロジピンの薬物間相互作用に関する後向き観察研究

日本病院薬剤師会雑誌, 52, 63-66 (2016)

2015年


Mishima E, Jinno D, Akiyama Y, Itoh K, Nankumo S, Shima H, Kikuchi K, Takeuchi Y, Elkordy A, Suzuki T, Niizuma K, Ito S, Tomioka Y, Abe T.

Immuno-Northern Blotting: Detection of RNA Modifications by Using Antibodies against Modified Nucleosides

PLoS ONE, 10, e0143756 (2015)

Inoue K, Takahashi T, Yamamoto Y, Suzuki E, Takahashi Y, Imai K, Inoue Y, Hirai K, Tsuji D, Itoh K.

Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy

Seizure, 33, 76-80 (2015)

Hirai K, Yamada Y, Hayashi H, Tanaka M, Izumiya K, Suzuki M, Yoshizawa M, Moriwaki H, Akimoto T, Tsuji D, Inoue K, Itoh K.

Plasma vitamin K concentrations depend on CYP4F2 polymorphism and influence on anticoagulation in Japanese patients with warfarin therapy

Thromb Res, 135, 861-866 (2015)

Tazoe Y, Hayashi H, Tsuboi S, Shioura T, Matsuyama T, Yamada H, Hirai K, Tsuji D, Inoue K, Sugiyama T, Itoh K.

Reduced folate carrier 1 gene expression levels are correlated with methotrexate efficacy in Japanese patients with rheumatoid arthritis

Drug Metab Pharmacokinet. 30, 227-230 (2015)

Ikeda M, Tsuji D, Yamamoto K, Kim Y, Daimon T, Iwabe Y, Hatori M, Makuta R, Hayashi H, Inoue K, Nakamichi H, Shiokawa M, Itoh K.

Relationship between ABCB1 gene polymorphisms and severe neutropenia in patients with breast cancer treated with doxorubicin/cyclophosphamide chemotherapy

Drug Metab Pharmacokinet, 30, 149-153 (2015)

2014年


羽鳥正浩辻 大樹,多久佳成,大門貴志,亀里真那池田 翠幕田 龍林 秀樹井上和幸伊藤邦彦.

ゲムシタビン施行切除不能膵がん患者における予後因子の検討

医療薬学. 40, 734-741 (2014)

Tsuji D, Kamezato M, Daimon T, Taku K, Hatori M, Ikeda M, Hayashi H, Inoue K, Eto T, Itoh K.

Retrospective Analysis of Severe Neutropenia in Patients Receiving Concomitant Administration of Docetaxel and Clarithromycin

Chemotherapy, 59, 407-413 (2013)

Inoue K, Suzuki E, Takahashi T, Yamamoto Y, Yazawa R, Imai K, Miyakawa K, Inoue Y, Tuji D, Hayashi H, Itoh K.

4217C>A polymorphism in carbamoyl-phosphate synthase 1 gene may not associate with hyperammonemia development during valproic acid-based therapy

Epilepsy Res., 108, 1046-1051 (2014)

Mishima E, Inoue C, Saigusa D, Inoue R, Ito K, Suzuki Y, Jinno D, Tsukui Y, Akamatsu Y, Araki M, Araki K, Shimizu R, Shinke H, Suzuki T, Takeuchi Y, Shima H, Akiyama Y, Toyohara T, Suzuki C, Saiki Y, Tominaga T, Miyagi S, Kawagisihi N10, Soga T, Ohkubo T, Yamamura K, Imai Y1, Masuda S, Sabbisetti V, Ichimura T, Mount DB, Bonventre JV, Ito S, Tomioka Y, Itoh K, Abe T.

Conformational Change in Transfer RNA Is an Early Indicator of Acute Cellular Damage

J Am Soc Nephrol., 25, 2316-2326 (2014)

Yokoyama Y, Osano A, Hayashi H, Itoh K, Okura T, Deguchi Y, Ito Y, Yamada S

Endothelin-1 Receptors in Rat Tissues: Characterization by Bosentan, Ambrisentan and CI-1020

Biol. Pharm. Bull., 37, 461-4651 (2014)

Saito M, Kondo M, Ohshima M, Deguchi K, Hayashi H, Inoue K, Tsuji D, Masuko T, Itoh K.

Identification of anti-CD98 antibody mimotopes for inducing antibodies with antitumor activity by mimotope immunization

Cancer Sci., 105, 396-401 (2014)

Osano A, Yokoyama Y, Hayashi H, Itoh K, Okura T, Deguchi Y, Ito Y, Yamada S.

Bladder Endothelin-1 Receptor Binding of Bosentan and Ambrisentan

J. Pharmacol. Sci., 124, 86-91 (2014)

Inoue K, Suzuki E, Yazawa R, Yamamoto Y, Takahashi T, Takahashi Y, Imai K, Koyama S, Inoue Y, Tsuji D, Hayashi H, Itoh K.
Influence of Uridine Diphosphate Glucuronosyltransferase 2B7 -161C>T Polymorphism on the Concentration of Valproic Acid in Pediatric Epilepsy Patients

Ther. Drug Monit.,36, 406-409 (2014)

Yokoyama Y, Tomatsuri M, Hayashi H, Hirai K, Ono Y, Yamada Y, Todoroki K, Toyo'oka T, Yamada H, Itoh K.

Simultaneous microdetermination of bosentan, ambrisentan, sildenafil, and tadalafil in plasma using liquid chromatography/tandem mass spectrometry for pediatric patients with pulmonary arterial hypertension

J. Pharm. Biomed. Anal., 89, 227-232 (2014)

2013年


大島幹弘,中村安孝,池田直人,西山博隆,小菅和仁,山田 浩,伊藤邦彦,松山耐至

バラつきの少ない錠剤分割法の検討

医療薬学, 39, 499-503 (2013)

Tsuji D, Kim YI, Nakamichi H, Daimon T, Suwa K, Iwabe Y, Hayashi H, Inoue K, Yoshida M, Itoh K.

Association of ABCB1 polymorphisms with the antiemetic efficacy of granisetron plus dexamethasone in breast cancer patients

Drug Metab. Pharmacokinrt., 28, 299-304 (2013)

大島幹弘,西山博隆,坪井声示,塩浦朋根,林 秀樹,伊藤邦彦,松山耐至

リウマチ患者における生物学的製剤投与時の併用薬への影響

医療薬学, 39, 388-393 (2013)

Hayashi H, Tazoe Y, Tsuboi S, Horino M, Morishita M, Arai T, Ohshima M, Matsuyama T, Kosuge K, Yamada H, Tsuji D, Inoue K, Itoh K.

A single nucleotide polymorphism of reduced folate carrier 1 predicts methotrexate efficacy in Japanese patients with rheumatoid arthritis

Drug Metab. Pharmacokinrt., 28, 164-168 (2013)

Hirai K, Hayashi H, Ono Y, Izumiya K, Tanaka M, Suzuki T, Sakamoto T, Itoh K.

Influence of CYP4F2 polymorphisms and plasma vitamin K levels on warfarin sensitivity in Japanese pediatric patients

Drug Metab. Pharmacokinrt., 28, 132-137 (2013)

Fujii S, Hayashi H, Itoh K, Yamada S, Deguchi Y, Kawazu K.

Characterization of the carrier-mediated transport of ketoprofen, a nonsteroidal anti-inflammatory drug, in rabbit corneal epithelium cells

J. Pharm. Pharmacol., 65, 171-180 (2013)

Yamamoto Y, Takahashi Y, Imai K, Mishima N, Yazawa R, Inoue K, Itoh K, Kagawa Y, Inoue Y.

Risk factors for hyperammonemia in pediatric patients with epilepsy

Epilepsia, 54, 983-989 (2013)

Inoue K, Sonobe M, Kawamura Y, Etoh T, Takagi M, Matsumura T, Kikuyama M, Kimura M, Minami S, Utsuki H, Yamazaki T, Suzuki T, Tsuji D, Hayashi H, Itoh K.

Polymorphisms of the UDP-glucuronosyl transferase 1A genes are associated with adverse events in cancer patients receiving irinotecan-based chemotherapy

Tohoku J. Exp. Med., 229, 107-114 (2013)

林 秀樹

遺伝子多型と薬物動態解析に基づく個別化薬物療法を目指した臨床薬理研究

薬学雑誌, 133, 1071-1085 (2013)

辻 大樹

がん領域の医薬品情報:ゲムシタビン

J. Oncol. Pharm., 5, 3-6 (2013)

伊藤邦彦

5.副作用発現に影響をおよぼす因子 Ⅱ個人的素因(トキシコゲノミクス)

図解 薬害・副作用学(南山堂), 122-127 (2013)

2012年


Nakamichi H, Fujita T, Tsuji D, Atsumi I, Totsuka K, Suzuki R, Miki Y, Tomita K, Nakamura H, Shiokawa M.

Analysis of risk factors of drug-induced lung injury in patients receiving gemcitabine treatment

Gan To Kagaku Ryoho, 39, 787-792 (2012)

Yamamoto Y, Takahashi Y, Suzuki E, Mishima N, Inoue K, Itoh K, Kagawa Y, Inoue Y.

Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients

Epilepsy Res., 101, 202-9 (2012)

大島幹弘、中村安孝、池田直人、望月美聡、曽根美由紀、坪井声示、林 秀樹、伊藤邦彦、小菅和仁、山田 浩、松山耐至

エタネルセプト25mg皮下注シリンジ週2回投与から50mg皮下注シリンジ週1回投与に変更した患者における有用性の評価

医療薬学, 38, 723-728(2012)

Inoue K, Ando N, Suzuki E, Hayashi H, Tsuji D, Itoh K.

Genotype distributions and allele frequencies of possible major depressive disorder-associated single nucleotide polymorphisms, cyclic adenosine monophosphate response element binding protein 1 rs4675690 and Piccolo rs2522833, in a Japanese population

Biol. Pharm. Bull., 35, 265-268 (2012)

Tsuji D, Kim YI, Taku K, Nakagaki S, Ikematsu Y, Tsubota H, Maeda M, Hashimoto N, Kimura M, Daimon T.

Comparative trial of two intravenous doses of granisetron (1 versus 3 mg) in the prevention of chemotherapy-induced acute emesis: a double-blind, randomized, non-inferiority trial

Support Care Cancer, 20, 1057-1064 (2012)

Hayashi H, Tazoe Y, Horino M, Fujimaki-Katoh C, Tsuboi S, Matsuyama T, Kosuge K, Yamada H, Tsuji D, Inoue K, Itoh K.

An artifact derived from pseudogene led to the discovery of micro RNA binding site polymorphism in 3′-untranslated region of human dihydrofolate reductase gene

Drug Metab. Pharmacokinet., 27, 263-267 (2012)

伊藤邦彦

臨床薬学演習のコンテンツ作成における大学連携のメリット

薬学雑誌, 132, 31-34 (2012)

2011年


Yoshida A, Hirooka Y, Sugata Y, Nitta M, Manabe T, Ido S, Murakami K, Saha RK, Suzuki T, Ohshima M, Yoshida A, Itoh K, Shimizu K, Oku N, Furuta T, Asakawa T, Wakimoto T, Kan T

Concise synthesis of catechin probes enabling analysis and imaging of EGCg

Chem. Commun., 47, 1794-1796 (2011)

賀川義之, 野口博司, 並木徳之, 林 秀樹, 小菅和仁

地域医療を支え,薬剤師の意欲を高めるリカレント教育と大学の役割

薬学雑誌, 131, 41-44 (2011)

2010年


Urushibata Y, Itoh K, Ohshima M, Seto Y

Generation of Fab Fragment-like Molecular Recognition Proteins against Staphylococcal Enterotoxin B by Phage Display Technology

Clin. Vaccine Immunol., 17, 1708-1717 (2010)

Ohshima M, Inoue K, Hayashi H, Tsuji D, Mizugaki M, Itoh K

Generation of AcGFP-labeled single-chain Fv against 5-methyl 2′-deoxycytidine from a hyperimmunized mouse using phage display technology

Protein Engineering, Design & Selection, 23, 881-888 (2010)

Hayashi H, Horino M, Morishita M, Tazoe Y, Tsuboi S, Matsuyama T, Kosuge K, Yamada H, Tsuji D, Inoue K, Itoh K

Dihydrofolate reductase gene intronic 19-bp deletion polymorphisms in a Japanese population

Drug Metab. Pharmacokinet., 25, 516-518 (2010)

坂和園子, 林 秀樹, 吉澤美沙, 堀野雅人, 森脇秀明, 秋本剛秀, 土井 修, 井上和幸, 辻 大樹, 河原崎貴伯, 伊藤邦彦

ワルファリン服用患者における出血リスクに対するプロトンポンプ阻害薬併用の影響

日本病院薬剤師会雑誌, 46, 535-538 (2010)

藤野知美, 伊藤由彦, 滝 優子, 柿澤希実, 尾上誠良, 今井康之, 奥 直人, 野口博司, 伊藤邦彦, 小林裕和, 大橋典男, 合田敏尚, 木苗直秀, 梅垣敬三, 渡邉祐司, 山田静雄

WarfarinとビタミンKの相互作用に関する文献的調査

臨床薬理, 41, 43-50 (2010)

Ohshima M, Tadakuma T, Hayashi H, Inoue K, Itoh K

Generation of a recombinant single-chain variable fragment (scFv) targeting 5-methyl-2'-deoxcytidine

J. Biochem., 147, 135-141 (2010)

2009年


林 秀樹, 神戸宏憲, 吉川俊博, 大門貴志, 鍋田いづみ, 木村 緑, 山田浩, 浮島美之, 井上和幸, 河原崎貴伯, 伊藤邦彦

がん化学療法における携帯型ディスポーザブル注入ポンプの流速変動因子の解析

日本病院薬剤師会雑誌, 45, 821-824 (2009)

Yoshizawa M, Hayashi H, Tashiro Y, Sakawa S, Moriwaki H, Akimoto T, Doi O, Kimura M, Kawarasaki Y, Inoue K, Itoh K

Effect of VKORC1 -1639 G>A polymorphism, body weight, age, and serum albumin alterationson warfarin response in Japanese patients

Thromb. Res., 124, 161-166 (2009)

Hayashi H, Fujimaki C, Daimon T, Tsuboi S, Matsuyama T, Itoh K

Genetic polymorphisms in folate pathway enzymes as a possible marker for predicting the outcome of methotrexate therapy in Japanese patients with rheumatoid arthritis

J. Clin. Pharm. Ther., 34, 355-361 (2009)

Fujimaki C, Hayashi H, Tsuboi S, Matsuyama T, Kosuge K, Yamada H, Inoue K, Itoh K

Plasma total homocysteine level and methylenetetrahydrofolate reductase 677C>T genetic polymorphism in Japanese patients with rheumatoid arthritis

Biomarkers, 14 49-54 (2009

Itoh K, Ohshima M, Sonobe M, Saito M, Yoshida A, Hayashi H, Inoue K, Masuko T

Antibody epitope peptides as a potent inducer of IgG antibodies againstCD98 oncoprotein.

Cancer Sci., 100, 126-131 (2009)

2008年


Hayashi H, Fujimaki C, Tsuboi S, Matsuyama T, Daimon T,Itoh K

Application of fluorescence polarization immunoassay for determination of methotrexate-polyglutamates in rheumatoid arthritis patients.

Tohoku J. Exp. Med., 215, 95-101 (2008)

Yoshida K., Higuchi H., Takahashi H., Kamata M., Sato K., Inoue K., Suzuki T., Itoh K., Ozaki, N.

Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferaseval58met polymorphism on the antidepressant effect of milnacipran.

Hum. Psychopharmacol., 23, 121-128 (2008)

2007年


Itoh K.

Development of diagnostically and therapeutically useful human antibody medicines by phage display system

Yakugaku Zasshi, 127, 43-53 (2007)

Inoue K, Itoh K, Yoshida K, Higuchi H, Kamata M, Takahashi H, Shimizu T, Suzuki T

No association of the G1287A polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population

Biol. Pharm. Bull. 30, 1996-1998 (2007)

Itoh K, Inoue K, Hayashi H, Suzuki T, Masuko T.

Identification of cell proliferation-associated epitope on CD98 oncoprotein using phage display random peptide library

Cancer Sci. 98 1696-1700 (2007)

Yoshida K, Higuchi H, Kamata M, Takahashi H, Inoue K, Suzuki T, Itoh K, Ozaki N.

The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine

J. Psychopharmacol. 21, 650-656 (2007)

Dong L., Masaki Y, Takegami T, Kawanami T, Itoh K, Jin Z-X, Huang C-R, Tong X-P, Fukushima T, Tanaka M, Sawaki T, Sakai T, Sugai S, Ozaki T, Hirose Y, Umehara H.

Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen

Int. Immunol. 19, 331-336 (2007)

Hayashi H, Fujimaki C, Inoue K, Suzuki T, Itoh K.

Genetic Polymorphism of C452T (T127I) in Human γ-Glutamyl Hydrolase in a Japanese Population

Biol. Pharm. Bull. 30, 839-841 (2007)

2006年


Watanabe M, Kazuta Y, Hayashi H, Yamada S, Matsuda A, Shuto S.

Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure

J. Med. Chem., 49, 5587-5596 (2006)

Masaki Y, Itoh K, Sawaki T, Karasawa H, Kawanami T, Fukushima T, Kawabata H, Wano Y, Hirose Y, Suzuki T, Sugai S, Umehara H.

Urinary pseudouridine in patients with lymphoma: Comparison with other clinical parameters

Clin. Chim. Acta., 371, 148-151 (2006)

井上和幸,伊藤邦彦,佐藤悦子,多田 均,鈴木敏夫

蛍光偏光免疫測定(FPIA)法による血中薬物濃度測定に及ぼす総ビリルビンの影響

日本病院薬剤師会雑誌, 42, 651-653 (2006)


後発医薬品採用のための品質評価 -マレイン酸エナラプリル錠における検討-

医療薬学,32, 306-313 (2006)

2005年


Seki, Y., Hayashi, K., Itoh, K., Mizugaki, M., Saitou, M. and Matsui, Y.

Extensive and orderly reprogramming of genome-wide hromatin modifications associated with specification and early development of germ cells in mice

Dev. Biol., 278, 440-458 (2005)

権守邦夫,渡部加奈子,伊藤邦彦,鳥海良寛,武藤 一,豊島 至,佐藤 滋,吉岡尚文,鈴木 修

秋田県における急性脳症の発生状況と原因究明への中毒学的アプローチ

中毒研究,18, 249-255 (2005)

contents


問合せ先
静岡県立大学 薬学部
臨床薬効解析学分野
教授 伊藤邦彦

〒422-8526
静岡市駿河区谷田52-1

TEL 054-264-5673 (代表)
FAX 054-264-5673 (代表)

ENGLISH